322 results on '"Gierlotka, M"'
Search Results
2. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
3. Development and validation of risk score for patients in primary care setting in Poland
4. Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study
5. Lipoprotein(a) is not a causal factor for the development of diabetes - a two-sample Mendelian randomization study
6. Klotho and FGF23 proteins levels and occurrence of myocardial infarction in patients with acute coronary syndrome
7. COVID-19 incidence and vaccination against SARS-Cov-2, influenza, and pneumococcal disease in patients with heart failure
8. Usefulness of the Klotho protein, FGF-23 and GDF-15 in assessment of the new onset Acute Heart Failure
9. Comparative analysis of ischemic and non-ischemic etiology of acute heart failure - analysis from the "OP-AHF" registry
10. Clinical characteristics, treatment and outcomes of acute heart failure patients over 65 years of age (analysis from the OP-AHF registry)
11. Relationship of obesity to mortality in 47,399 patients from nationwide LIPIDOGRAM 2004–2015 cohort studies
12. LDL levels and long-term all-cause mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies
13. Ordinal scoring of coronary artery calcification in low dose computed tomography is predictive factor of all-cause death and cardiovascular events
14. Lean metabolic syndrome is associated with similar long-term prognosis as metabolic syndrome in overweight/obese patients. Analysis 47,399 Patients from nationwide LIPIDOGRAM 2004–2015 cohort studies
15. Protective role of protein Klotho biomarker in acute heart failure
16. FGF-23 as a predictor of 6-month outcome and response to therapy in acute heart failure
17. Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study
18. Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
19. Current status and needs for changes in critical care training: the voice of the young cardiologists
20. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
21. Predictors of diuresis response to levosimendan administration in patients with acute heart failure
22. Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study
23. Organization of intensive cardiac care units in Europe: Results of a multinational survey
24. Strict compliance with ESC therapeutic guidelines after myocardial infarction treated with invasive strategy correlates with improved 18-month outcomes
25. Managed care improves prognosis in acute myocardial infarction survivors. Data from the MAnaged Care for Acute Myocardial Infarction Survivors (MACAMIS) Programme
26. P1750YKL-40 in patients with myocardial infarction is associated with survival rate
27. P1699Non-ST segment elevation miocardial infarction (NSTEMI) vs. Unstable angina (UA) in young women aged < 45 years - differences in symptomatology, clinical course, treatment and prognosis
28. P1743Assessment of quality of care of patients with ST-segment elevation myocardial infarction in Poland
29. P4801Antithrombotic management in patients with atrial fibrillation and acute coronary syndromes
30. P3644Independent predictors of very long-term outcomes of patients with stable angina - insights from The Prospective REgistry of Stable Angina manaGment and trEatment (PRESAGE) Registry
31. P2684Obesity paradox in patients with stable angina - insights from The Prospective REgistry of Stable Angina manaGEment and treatment (PRESAGE) Registry
32. P831Quality indicators of health care services in the management of patients with ST-elevation myocardial infarction
33. 1465Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study
34. P579Sex effect on mortality in STEMI - a retrospective analysis of a large nationwide database
35. 51Atrial fibrillation: 10 - year trends in epidemiology and prognosis for patients hospitalized in the Silesia region
36. Epidemiological analysis of hospitalizations due to acute stroke in the industrial region of Poland (Silesia) for the years 2009-2015
37. P891Comparison of outcomes in patients undergoing rotational atherectomy after unsuccessful coronary angioplasty versus elective rotational atherectomy
38. P6465Coronary revascularization in patients with extremely impaired left ventricular function - new frontier for percutaneous revascularization or still no-man's land?
39. P4675Comparison of multivessel percutaneous coronary intervention with coronary artery bypass grafting for patients with severe coronary artery disease and non-ST-segment elevation acute coronary syndromes
40. P5553Survival benefit from advances in the management of patients with STEMI in the PCI era - A propensity score-matched analysis
41. P2773Intraaortic balloon pump and 12-month mortality in cardiogenic shock AMI patients with unsuccessful and successful primary PCI - analysis from PL-ACS Registry
42. P4677Cause of death in patients discharged from the hospital after successful percutaneous treatment of non-ST-elevation myocardial infarction
43. P6474Contemporary management of coronary artery disease in heart failure with reduced ejection fraction. Guidelines meet clinical practice
44. P3659Early and 12-month mortality among the young woman and men with acute myocardial infarction (analysis from the PL-ACS registry)
45. P5573Differences in symptomatology and clinical course of acute cardiac syndroms (ACS) in the population of young woman <45 years of age
46. Long-term results of multivessel and left main coronary artery stenting in comparison with surgical revascularisation in patients with NSTE-ACS: the MILESTONE registry
47. 30-days outcome in NSTEMI patients treated with PCI is worse in those receiving GP IIb/IIIa blockers
48. Postprocedural TIMI flow grade 2 in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary revascularization. (PL-ACS Registry)
49. Prognosis in patients with stable coronary artery disease who would have not met criteria for the COURAGE trial
50. Are Elderly Patients with Acute Coronary Syndromes Undertreated? Data from Euro Heart Survey on ACS III Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.